HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Collagen-covered autologous chondrocyte implantation for osteochondritis dissecans of the knee: two- to seven-year results.

Abstract
We prospectively studied the clinical, arthroscopic and histological results of collagen-covered autologous chondrocyte implantation (ACI-C) in patients with symptomatic osteochondritis dissecans of the knee. The study included 37 patients who were evaluated at a mean follow-up of 4.08 years. Clinical results showed a mean improvement in the modified Cincinnati score from 46.1 to 68.4. Excellent and good clinical results were seen in 82.1% of those with juvenile-onset osteochondritis dissecans but in only 44.4% of those with adult-onset disease. Arthroscopy at one year revealed International Cartilage Repair Society grades of 1 or 2 in 21 of 24 patients (87.5%). Of 23 biopsies, 11 (47.8%) showed either a hyaline-like or a mixture of hyaline-like and fibrocartilage, 12 (52.2%) showed fibrocartilage. The age at the time of ACI-C determined the clinical outcome for juvenile-onset disease (p = 0.05), whereas the size of the defect was the major determinant of outcome in adult-onset disease (p = 0.01).
AuthorsS P Krishnan, J A Skinner, R W J Carrington, A M Flanagan, T W R Briggs, G Bentley
JournalThe Journal of bone and joint surgery. British volume (J Bone Joint Surg Br) Vol. 88 Issue 2 Pg. 203-5 (Feb 2006) ISSN: 0301-620X [Print] England
PMID16434524 (Publication Type: Journal Article)
Chemical References
  • Collagen
Topics
  • Adolescent
  • Adult
  • Age of Onset
  • Aging (physiology)
  • Analysis of Variance
  • Arthroscopy (methods)
  • Cartilage, Articular (pathology, surgery)
  • Child
  • Chondrocytes (transplantation)
  • Collagen (therapeutic use)
  • Humans
  • Knee Joint (pathology, surgery)
  • Osteochondritis Dissecans (pathology, surgery)
  • Postoperative Complications
  • Prospective Studies
  • Transplantation, Autologous
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: